IL147261A0 - Ambroxol-containing lozenge - Google Patents

Ambroxol-containing lozenge

Info

Publication number
IL147261A0
IL147261A0 IL14726100A IL14726100A IL147261A0 IL 147261 A0 IL147261 A0 IL 147261A0 IL 14726100 A IL14726100 A IL 14726100A IL 14726100 A IL14726100 A IL 14726100A IL 147261 A0 IL147261 A0 IL 147261A0
Authority
IL
Israel
Prior art keywords
tablet
ambroxol
pressing
containing lozenge
amobroxol
Prior art date
Application number
IL14726100A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7914872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL147261(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL147261A0 publication Critical patent/IL147261A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dry Formation Of Fiberboard And The Like (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cosmetics (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Confectionery (AREA)
IL14726100A 1999-07-20 2000-07-07 Ambroxol-containing lozenge IL147261A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19933148A DE19933148A1 (de) 1999-07-20 1999-07-20 Ambroxolhaltige Lutschtablette
PCT/EP2000/006437 WO2001005378A1 (de) 1999-07-20 2000-07-07 Ambroxolhaltige lutschtablette

Publications (1)

Publication Number Publication Date
IL147261A0 true IL147261A0 (en) 2002-08-14

Family

ID=7914872

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14726100A IL147261A0 (en) 1999-07-20 2000-07-07 Ambroxol-containing lozenge
IL147261A IL147261A (en) 1999-07-20 2001-12-23 A pill containing ambroxol

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147261A IL147261A (en) 1999-07-20 2001-12-23 A pill containing ambroxol

Country Status (33)

Country Link
US (1) US6663889B1 (xx)
EP (2) EP1352646A3 (xx)
JP (1) JP3776041B2 (xx)
KR (1) KR100743846B1 (xx)
CN (1) CN1164263C (xx)
AT (1) ATE246493T1 (xx)
AU (1) AU776906B2 (xx)
BG (1) BG65503B1 (xx)
BR (1) BRPI0012553B8 (xx)
CA (1) CA2379314C (xx)
CZ (1) CZ301981B6 (xx)
DE (2) DE19933148A1 (xx)
DK (1) DK1200070T3 (xx)
EA (1) EA004044B1 (xx)
EE (1) EE04797B1 (xx)
ES (1) ES2173823T3 (xx)
HK (1) HK1045946B (xx)
HR (1) HRP20020050B1 (xx)
HU (1) HU229040B1 (xx)
IL (2) IL147261A0 (xx)
ME (1) MEP36808A (xx)
MX (1) MXPA02000546A (xx)
NO (1) NO331306B1 (xx)
NZ (1) NZ516987A (xx)
PL (1) PL197175B1 (xx)
PT (1) PT1200070E (xx)
RS (1) RS50246B (xx)
SI (1) SI1200070T1 (xx)
SK (1) SK284290B6 (xx)
TR (1) TR200200106T2 (xx)
UA (1) UA73313C2 (xx)
WO (1) WO2001005378A1 (xx)
ZA (1) ZA200200384B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
DE102005018561A1 (de) * 2005-04-21 2006-11-02 Giesecke & Devrient Gmbh Verfahren zum Betreiben eines Systems mit einem tragbaren Datenträger und einem Endgerät
DE102010009369A1 (de) 2010-02-25 2011-08-25 Boehringer Ingelheim International GmbH, 55218 Kindergesicherte Verpackung für Ambroxolhaltige Lutschtabletten
JP2014503542A (ja) 2010-12-23 2014-02-13 レクティオ ファーマエントヴィクラングス− ウント フェルヴェルタングス ゲゼルシャフト ミット ベシュレンクテル ハフツング アンブロキソールの水溶液
ES2864774T3 (es) 2011-12-22 2021-10-14 Centogene Ip Gmbh Combinación de un compuesto que tiene la capacidad de reorganizar una enzima lisosomal y Ambroxol y/o un derivado de Ambroxol
EP3538083B1 (en) 2016-11-14 2024-07-10 NeuVision Development LLC Formulations for the treatment of ocular surface diseases and related methods
MX2017014725A (es) * 2017-11-16 2019-05-17 Productos Farm S A De C V Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034975C2 (de) * 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Arzneimittelkombination zur Behandlung infektiöser Atemwegerkrankungen
EP0138020B1 (de) * 1983-09-17 1992-06-03 Dr. Karl Thomae GmbH Antiadhäsive Prophylactica und Arzneimittel enthaltend ein sekretolytisch wirksames Benzylaminderivat
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt

Also Published As

Publication number Publication date
BRPI0012553B8 (pt) 2021-05-25
HK1045946B (zh) 2005-01-28
EE200200027A (et) 2003-04-15
ZA200200384B (en) 2002-10-30
HRP20020050B1 (en) 2004-06-30
UA73313C2 (uk) 2005-07-15
US6663889B1 (en) 2003-12-16
BG65503B1 (bg) 2008-10-31
EA004044B1 (ru) 2003-12-25
MXPA02000546A (es) 2002-07-30
NO20020274D0 (no) 2002-01-18
EP1200070A1 (de) 2002-05-02
HUP0202021A3 (en) 2004-05-28
CN1164263C (zh) 2004-09-01
DE19933148A1 (de) 2001-01-25
NZ516987A (en) 2003-08-29
WO2001005378A1 (de) 2001-01-25
JP2003522125A (ja) 2003-07-22
CA2379314A1 (en) 2001-01-25
PL352276A1 (en) 2003-08-11
TR200200106T2 (tr) 2002-07-22
KR100743846B1 (ko) 2007-08-02
PT1200070E (pt) 2003-12-31
SK284290B6 (sk) 2005-01-03
YU3802A (sh) 2004-09-03
EE04797B1 (et) 2007-04-16
EP1352646A3 (de) 2004-01-07
ATE246493T1 (de) 2003-08-15
HUP0202021A2 (hu) 2002-11-28
ES2173823T3 (es) 2004-04-16
BR0012553A (pt) 2002-04-16
SK812002A3 (en) 2002-06-04
HK1045946A1 (en) 2002-12-20
KR20020012316A (ko) 2002-02-15
NO331306B1 (no) 2011-11-21
MEP36808A (en) 2011-02-10
AU776906B2 (en) 2004-09-23
CN1364075A (zh) 2002-08-14
AU6269900A (en) 2001-02-05
HU229040B1 (en) 2013-07-29
CZ20014633A3 (cs) 2002-03-13
IL147261A (en) 2006-12-31
EA200200091A1 (ru) 2002-06-27
DK1200070T3 (da) 2003-10-06
SI1200070T1 (en) 2003-12-31
BR0012553B1 (pt) 2014-05-27
RS50246B (sr) 2009-07-15
EP1200070B1 (de) 2003-08-06
DE50003209D1 (de) 2003-09-11
CZ301981B6 (cs) 2010-08-25
NO20020274L (no) 2002-03-13
CA2379314C (en) 2007-09-11
BG106316A (en) 2002-08-30
JP3776041B2 (ja) 2006-05-17
EP1352646A2 (de) 2003-10-15
PL197175B1 (pl) 2008-03-31
ES2173823T1 (es) 2002-11-01
HRP20020050A2 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
HRP20020050B1 (en) Ambroxol-containing lozenge
EP1040827A3 (en) Use of 2-alkylpyrrolidines for the treatment of diabetes
CA2472194A1 (en) An inhalation actuated device
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
GB2298162A (en) Padding
IL151690A0 (en) Medicaments for complications of diabetes and neuropathy, and uses thereof
WO2003051293A3 (en) Antidiabetic formulation and method
DK0996653T3 (da) Phenolresin til limsammensætning, fremgangsmåde til fremstilling deraf og limsammensætning indeholdende den
GR3018245T3 (en) An adhesive composition comprising isocyanate, phenol-formaldehyde and tannin, useful for manufacturing plywoods for exterior application.
EP1433583A4 (en) DAMPING MATERIAL FOR HOT PRESSING AND PRODUCTION PROCESS THEREFOR
AU7525498A (en) Interactive system for substance presentation and elimination
EP0901796A3 (en) Encapsulation device
AU2277497A (en) Porcine reproductive and respiratory syndrome vaccine
WO2001026638A3 (en) The use of baclofen in the treatment of alcoholism
NZ335078A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
AU2001291844A1 (en) Xenon as medicament
AU2001259295A1 (en) Method and composition for rapid delivery of bioactive compounds to the systemiccirculation via the nasal membrane
WO2002057313A8 (en) Receptor-binding compounds and methods for identifying them
MX9602321A (es) Adhesivos de uretano de curado en humedad que contienen -butirolactona.
WO2004006831A3 (en) Method and device for inducing biological processes by micro-organs
AU5268101A (en) Porous phenol resin grindstone and method for its preparation
AU5848400A (en) Novel physiologically active substance, process for producing the same and use thereof
WO2003004380A3 (en) Packaging for a solid
AU3110595A (en) Exchangeable mouthpiece for inhalers with integrated, consolidated, ring-shaped active substance tablet
AU4635801A (en) Plaster containing an active agent

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed